本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Precigen

1.55
-0.0100-0.64%
盘后1.580.0280+1.81%16:39 EDT
成交量:70.81万
成交额:110.45万
市值:4.56亿
市盈率:-3.29
高:1.60
开:1.58
低:1.52
收:1.56
数据加载中...

公司资料

公司名字:
Precigen
交易所:
NASDAQ
成立时间:
1998
员工人数:
143
公司地址:
20374 Seneca Meadows Parkway,Germantown,Maryland,United States
邮编:
20876
电话:
传真:
- -
简介:
Precigen, Inc.成立于俄亥俄州有限责任公司。该公司于2004年重新注册为弗吉尼亚州公司。Precigen, Inc.是合成生物学领域的领导者,合成生物学是一门新兴且快速发展的学科,将工程原理应用于生物系统。该公司利用其专有和互补技术套件,设计、构建和调控基因程序,这些程序是由关键遗传成分组成的DNA序列。

董事

名称
职位
Randal J. Kirk
Director,Chief Executive Officer and Chairman
Cesar L. Alvarez
Director
Dean J. Mitchell
Director
Fred Hassan
Director
James S. Turley
Director
Jeffrey B. Kindler
Director
Robert B. Shapiro
Director
Steven Frank
Director
Vinita D. Gupta
Director

股东

名称
职位
Randal J. Kirk
Director,Chief Executive Officer and Chairman
Thomas P. Bostick
Chief Operating Officer
Jeffrey T. Perez
Senior Vice President, Intellectual Property Affairs
Joel Liffmann
Senior Vice President, Finance
Rick L. Sterling
Chief Financial Officer
Robert F. Walsh, III
Senior Vice President, Energy & Fine Chemicals
Donald Lehr
Chief Legal Officer
Helen Sabzevari
President, Precigen, Inc.
Nir Nimrodi
Chief Business Officer
Thomas D. Reed
Founder and Chief Science Officer